Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas
Department of Pathology
Antigens, Neoplasm; Carcinoma, Papillary; Carcinoma, Renal Cell; Disease-Free Survival; Humans; Kidney Neoplasms; Neoplasm Proteins; RNA-Binding Proteins; Tumor Markers, Biological
Life Sciences | Medicine and Health Sciences
BACKGROUND: Whether an oncofetal protein, IMP3, can serve as a prognostic biomarker to predict metastasis for patients with localized papillary and chromophobe subtypes of renal cell carcinomas (RCCs) was investigated.
METHODS: The expression of IMP3 in 334 patients with primary papillary and chromophobe RCC from multiple medical centers was evaluated by immunohistochemistry. The 317 patients with localized papillary and chromophobe RCCs were further evaluated for outcome analyses.
RESULTS: IMP3 was significantly increased in a subset of localized papillary and chromophobe RCCs that subsequently metastasized. Patients with localized IMP3-positive tumors (n=33; 10%) were over 10 times more likely to metastasize (risk ratio [RR], 11.38; 95% confidence interval [CI], 5.40-23.96; PCONCLUSIONS: IMP3 is an independent prognostic biomarker that can be used to identify a subgroup of patients with localized papillary and chromophobe RCC who are at high risk for developing distant metastasis.
DOI of Published Version
Cancer. 2008 Jun 15;112(12):2676-82. Link to article on publisher's site
Jiang Z, Lohse CM, Chu PG, Wu C, Woda BA, Rock KL, Kwon ED. (2008). Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas. Open Access Publications by UMMS Authors. https://doi.org/10.1002/cncr.23484. Retrieved from https://escholarship.umassmed.edu/oapubs/1957